Sponsor Pipeline

Ossium Health, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
8
Disease Areas
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-21 NCT05589896
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased…		 overall status: Recruiting → Active, Not Recruiting
2026-07-21 NCT05589896
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased…		 date change Primary completion pushed: 2026-05-31 -> 2026-07-14
2026-07-21 NCT05589896
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased…		 date change Completion pushed: 2027-03-31 -> 2029-05-31
Active Trials by Phase
Phase 1/2
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT05589896 A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased… Acute Leukemia Active, Not Recruiting
Not specified
NCT07145411 HPC Offered for PRESERVE Expansion Bone Marrow Transplant (BMT) Recruiting
NCT07710781 Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor… Hematologic Malignancy Not Yet Recruiting
Disease Areas
Leukemia (2) Acute Myeloid Leukemia (AML) (2) Acute Lymphoblastic Leukemia (ALL) (2) Chronic Lymphocytic Leukemia (CLL) (2) Chronic Myeloid Leukemia (CML) (2) Non-Hodgkin Lymphoma (2) Myelodysplastic Syndromes (MDS) (2) Hodgkin Lymphoma (1)
Get alerts when Ossium Health, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free